학술논문

Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR -Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301.
Document Type
Article
Source
Journal of Clinical Oncology; 9/10/2023, Vol. 41 Issue 26, p4208-4217, 15p
Subject
Language
ISSN
0732183X